Symbol="ACLX"
AssetType="Common Stock"
Name="Arcellx Inc"
Description="Arcellx, Inc., a clinical-stage biotechnology company, is engaged in the development of various immunotherapies for patients with cancer and other incurable diseases. The company is headquartered in Gaithersburg, Maryland."
CIK="1786205"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="25 WEST WATKINS MILL ROAD, SUITE A, GAITHERSBURG, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1546351000"
EBITDA="-194135008"
PERatio="None"
PEGRatio="None"
BookValue="6.35"
DividendPerShare="0"
DividendYield="0"
EPS="-4.51"
RevenuePerShareTTM="0.418"
ProfitMargin="0"
OperatingMarginTTM="-10.92"
ReturnOnAssetsTTM="-0.281"
ReturnOnEquityTTM="-0.715"
RevenueTTM="17912000"
GrossProfitTTM="0"
DilutedEPSTTM="-4.51"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="49.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="6.12"
EVToRevenue="-"
EVToEBITDA="-7.34"
Beta="None"
num_52WeekHigh="48.91"
num_52WeekLow="15.63"
num_50DayMovingAverage="39.91"
num_200DayMovingAverage="29.82"
SharesOutstanding="47993500"
DividendDate="None"
ExDividendDate="None"
symbol="ACLX"
open="31.46"
high="32.69"
low="30.74"
price="32.22"
volume="483901.00"
latest_trading_day="2023-07-05"
previous_close="31.51"
change="0.71"
change_percent="2.2533%"
aroon_positive_momentum_days="74"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="74"
Volume_recent_avg="559372"
Change_recent_avg="0.03"
Delta_recent_avg="1.96"
Variance_recent_avg="0.98"
Change_ratio_recent_avg="0.04"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="74"
Aroon_momentum_negative="26"
image_negative_thumbnail_id_1="1127"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0160.jpeg"
image_negative_thumbnail_id_2="494"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0111.jpeg"
image_neutral_thumbnail_id_1="571"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="641"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0067.jpeg"
image_positive_thumbnail_id_2="605"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0103.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
